Home › Sarepta Therapeutics Announces Plans To Submit Rolling NDA For Eteplirsen Following Today's Pre-NDA Meeting With The FDA
 

Keywords :   


Sarepta Therapeutics Announces Plans To Submit Rolling NDA For Eteplirsen Following Today's Pre-NDA Meeting With The FDA

2015-06-03 06:47:48| drugdiscoveryonline Home Page

Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics, recently announced that the Company held a pre-New Drug Application (NDA) meeting with the U.S

Tags: the with submit plans

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.06Atlantic Tropical Weather Outlook
23.06Eastern North Pacific Tropical Weather Outlook
22.06AI and agriculture: A look at whats ahead
22.06Atlantic Tropical Weather Outlook
22.06Atlantic Tropical Weather Outlook
22.06Eastern North Pacific Tropical Weather Outlook
22.06This Week in Agribusiness, June 22, 2024
22.06This Week in Agribusiness, June 22, 2024
More »